Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What Will Novartis Do With $13bn Cash Pile From GSK?

Executive Summary

The Swiss major has divested a non-core asset at a decent price and its eye care unit Alcon could be next under the hammer as CEO Vas Narasimhan looks at bolt-on acquisitions to create "the leading medicines company, powered by digital and data."

Advertisement

Related Content

Novartis Blows Storm Clouds Off Sandoz US In Aurobindo Sale
Novartis Blows Storm Clouds Off Sandoz US In Aurobindo Sale
Takeda's Interest Likely To Flush Out Further Shire Suitors
GSK Exercises Right To Buy Out Novartis Consumer Healthcare JV For $13bn
Digital Gets Top Billing As Novartis CEO Wields Management Broom
Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact
Roche To Improve Real-World Cancer Data Extraction With Flatiron Buy
Novartis Sale Of US Oral Generics Unit Seems Unlikely
Lutathera Approval Positions Novartis To Regain NET Share Taken By Ipsen
Interview: Sandoz CEO On Biosimilars And Reshaping US Business

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100642

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel